{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:26:39Z","timestamp":1785882399348,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jconrel.2012.05.041","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T05:10:30Z","timestamp":1338441030000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl4-induced fibrogenesis in mice"],"prefix":"10.1016","volume":"162","author":[{"given":"Adriana","family":"Mattos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alie","family":"de Jager-Krikken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2012.05.041_bb0005","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis \u2014 from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","article-title":"Matrix as a modulator of hepatic fibrogenesis","volume":"21","author":"Schuppan","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0020","first-page":"1333","article-title":"Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat","volume":"137","author":"Abdel Aziz","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0025","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0030","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","article-title":"Reversal of hepatic fibrosis \u2014 fact or fantasy?","volume":"43","author":"Friedman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O'Garra","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.174.4.915","article-title":"Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression","volume":"174","author":"de Waal Malefyt","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0050","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1074\/jbc.273.1.302","article-title":"Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0055","doi-asserted-by":"crossref","first-page":"G981","DOI":"10.1152\/ajpgi.00293.2001","article-title":"IL-10 receptor and coreceptor expression in quiescent and activated hepatic stellate cells","volume":"282","author":"Mathurin","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2174\/1573406410602060611","article-title":"The effects of interleukin-10 on the expression of Fas and FasL in rat hepatic stellate cells","volume":"2","author":"Zhang","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0065","first-page":"859","article-title":"Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect","volume":"38","author":"Nelson","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0070","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1023\/B:PHAM.0000048199.94510.b0","article-title":"Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis","volume":"21","author":"Rachmawati","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"PEGylation: a novel process for modifying pharmacokinetics","volume":"40","author":"Harris","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-409X(02)00022-4","article-title":"Chemistry for peptide and protein PEGylation","volume":"54","author":"Roberts","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat1159","article-title":"Multiphoton microscopy guides neurotrophin modification with poly(ethylene glycol) to enhance interstitial diffusion","volume":"3","author":"Stroh","year":"2004","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jbm.a.32254","article-title":"PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution","volume":"91","author":"Soderquist","year":"2009","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/bc049713n","article-title":"A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation","volume":"16","author":"Rosendahl","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jbm.a.32611","article-title":"PEGylation of interleukin-10 for the mitigation of enhanced pain states","volume":"93","author":"Soderquist","year":"2010","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2011.05.027","article-title":"PEGylation improves pharmacokinetic profile, liver uptake and efficacy of interferon gamma in liver fibrosis","volume":"154","author":"Bansal","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0110","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0003-2697(81)90783-1","article-title":"Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity","volume":"117","author":"Morrissey","year":"1981","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0115","first-page":"1034","article-title":"High efficiency iodination of monoclonal antibodies for radiotherapy","volume":"28","author":"Mather","year":"1987","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0120","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.275.17.12743","article-title":"Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor","volume":"275","author":"Beljaars","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0125","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.510290526","article-title":"Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells","volume":"29","author":"Beljaars","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2010.08.040","article-title":"Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system","volume":"400","author":"Carvalho","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1074-7613(00)80404-5","article-title":"Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling","volume":"7","author":"Koppelman","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0140","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2007.03353.x","article-title":"Lymphocyte\u2013hepatic stellate cell proximity suggests a direct interaction","volume":"148","author":"Muhanna","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0145","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","article-title":"Anti-inflammatory cytokines","volume":"117","author":"Opal","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0155","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ni.1990","article-title":"IRF5 promotes inflammatory macrophage polarization and TH1\u2013TH17 responses","volume":"12","author":"Krausgruber","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0160","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.20100730","article-title":"Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth","volume":"208","author":"Manrique","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/bbrc.2001.4321","article-title":"Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1","volume":"281","author":"Yamamoto","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0170","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1681\/ASN.2005030297","article-title":"IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease","volume":"16","author":"Mu","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0175","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/jps.21278","article-title":"The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics","volume":"97","author":"Fishburn","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V87.2.699.bloodjournal872699","article-title":"Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers","volume":"87","author":"Huhn","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0185","first-page":"67","article-title":"Interleukin-10 pharmacokinetics in intact and nephrectomized mice","volume":"7","author":"Chiu","year":"1996","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0190","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/pro.5560070412","article-title":"Mapping of the interleukin-10\/interleukin-10 receptor combining site","volume":"7","author":"Reineke","year":"1998","journal-title":"Protein Sci."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0195","doi-asserted-by":"crossref","first-page":"L1196","DOI":"10.1152\/ajplung.2001.280.6.L1196","article-title":"Interleukin-10-mediated inhibition of free radical generation in macrophages","volume":"280","author":"Dokka","year":"2001","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yexmp.2005.08.007","article-title":"Serological and immunohistochemical studies on porcine-serum-induced hepatic fibrosis in rats","volume":"79","author":"Baba","year":"2005","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0205","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yexmp.2004.08.001","article-title":"MHC class II-related genes expression in porcine-serum-induced rat hepatic fibrosis","volume":"77","author":"Baba","year":"2004","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/cimm.2000.1687","article-title":"Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts","volume":"204","author":"Song","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0225","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2012.05.041_bb0230","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.4049\/jimmunol.181.10.7214","article-title":"IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis","volume":"181","author":"Herbert","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0235","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/827565","article-title":"Foxp3 expression in liver correlates with the degree but not the cause of inflammation","volume":"2011","author":"Speletas","year":"2011","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.jconrel.2012.05.041_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/345803","article-title":"Role of IL-17 and Th17 cells in liver diseases","volume":"2011","author":"Hammerich","year":"2011","journal-title":"Clin. Dev. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365912004543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:26:59Z","timestamp":1759159619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365912004543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0168365912004543"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylation of interleukin-10 improves the pharmacokinetic profile and enhances the antifibrotic effectivity in CCl4-induced fibrogenesis in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2012.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}